Virmani R - Search Results

1

First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model.

Stefanadis C, Toutouzas K, Stefanadi E, Kolodgie F, Virmani R, Kipshidze N. Stefanadis C, et al. Among authors: virmani r. Hellenic J Cardiol. 2006 Jan-Feb;47(1):7-10. Hellenic J Cardiol. 2006. PMID: 16532709 Free article.

2

Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%).

Kolodgie FD, Virmani R, Farb A. Kolodgie FD, et al. Among authors: virmani r. J Am Coll Cardiol. 1991 Jul;18(1):215-23. doi: 10.1016/s0735-1097(10)80242-6. J Am Coll Cardiol. 1991. PMID: 2050924 Free article.

3

Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty.

Farb A, Virmani R, Atkinson JB, Kolodgie FD. Farb A, et al. Among authors: virmani r. J Am Coll Cardiol. 1990 Nov;16(6):1421-9. doi: 10.1016/0735-1097(90)90386-4. J Am Coll Cardiol. 1990. PMID: 2229795 Free article.

4

Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits.

Kolodgie FD, Virmani R, Rice HE, Mergner WJ. Kolodgie FD, et al. Among authors: virmani r. Circ Res. 1990 Apr;66(4):1112-26. doi: 10.1161/01.res.66.4.1112. Circ Res. 1990. PMID: 2317889

5

The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.

Virmani R, Osmialowski AF, Kolodgie FD, Forman MB. Virmani R, et al. Am J Cardiovasc Pathol. 1990;3(1):69-80. Am J Cardiovasc Pathol. 1990. PMID: 2331363

6

Myocardial reperfusion injury. Histopathological effects of perfluorochemical.

Virmani R, Forman MB, Kolodgie FD. Virmani R, et al. Circulation. 1990 Mar;81(3 Suppl):IV57-68. Circulation. 1990. PMID: 2407375 Review.

7

Early detection and measurement of experimental myocardial infarcts with horseradish peroxidase.

Farb A, Kolodgie FD, Jones RM, Jenkins M, Virmani R. Farb A, et al. Among authors: virmani r. J Mol Cell Cardiol. 1993 Apr;25(4):343-53. doi: 10.1006/jmcc.1993.1041. J Mol Cell Cardiol. 1993. PMID: 7688052

8

Pathobiological determinants of cocaine-associated cardiovascular syndromes.

Kolodgie FD, Farb A, Virmani R. Kolodgie FD, et al. Among authors: virmani r. Hum Pathol. 1995 Jun;26(6):583-6. doi: 10.1016/0046-8177(95)90160-4. Hum Pathol. 1995. PMID: 7774885 No abstract available.

9

Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.

Kolodgie FD, Farb A, Carlson GC, Wilson PS, Virmani R. Kolodgie FD, et al. Among authors: virmani r. J Am Coll Cardiol. 1994 Oct;24(4):1098-108. doi: 10.1016/0735-1097(94)90876-1. J Am Coll Cardiol. 1994. PMID: 7930204 Free article.

10

Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: the role of vascular endothelium.

Kolodgie FD, Wilson PS, Cornhill JF, Herderick EE, Mergner WJ, Virmani R. Kolodgie FD, et al. Among authors: virmani r. Toxicol Pathol. 1993 Sep-Oct;21(5):425-35. doi: 10.1177/019262339302100501. Toxicol Pathol. 1993. PMID: 8115819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,112 results

Search Page